Abirakast – Prostate Cancer Treatment

oncology  /  Abirakast

Abirakast

Abirakast is a medication containing Abiraterone Acetate, designed for the treatment of advanced prostate cancer in men. It functions by inhibiting the CYP17 enzyme, which plays a critical role in the... Abirakast is a medication containing Abiraterone Acetate, designed for the treatment of advanced prostate cancer in men. It functions by inhibiting the CYP17 enzyme, which plays a critical role in the production of androgens (male hormones) that stimulate the growth of prostate cancer cells. By reducing androgen levels in the body, Abirakast helps to slow the progression of metastatic castration-resistant prostate cancer (mCRPC), improving survival rates and the quality of life for patients. It is usually administered in combination with prednisone to enhance its therapeutic effectiveness while managing potential side effects. Abirakast is produced under strict quality standards to ensure safety, effectiveness, and consistency in treatment, providing patients with a reliable option for managing advanced stages of prostate cancer under the supervision of a healthcare professional. Read more Hide

• Active ingredient:
  Abiraterone Acetate
• Manufacturer: Aprazer
• Dosage: 250 mg
• Dosage form: Tablets
• Units per pack: 120
• Delivery across Ukraine
• 100% original product